
spectrobid
Pharmaranks rates Spectrobid 3.0/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Spectrobid (Bacampicillin Hydrochloride) is a medication used to treat Escherichia Coli Infections, Gonorrhea, Haemophilus Infections, Listeriosis.
Bacampicillin Hydrochloride · by Pfizer
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Bacampicillin Hydrochloride
- Form
- Tablet
- Strength
- Bacampicillin Hydrochloride 125MG/5ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Pfizer
- FDA application
- NDA050556
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Spectrobid treat?
- Spectrobid (Bacampicillin Hydrochloride) may be used to treat escherichia coli infections, gonorrhea, haemophilus infections, listeriosis, proteus infections, respiratory tract infections, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Spectrobid rated?
- pharmaranks gives Spectrobid a composite score of 3.0 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Spectrobid?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Spectrobid. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Spectrobid?
- Spectrobid is marketed by Pfizer. You can see Pfizer's full profile, rating, and other products on pharmaranks.
- Is Spectrobid a brand-name or generic drug?
- Spectrobid is a brand-name product with the active ingredient Bacampicillin Hydrochloride.
- Is Spectrobid available over the counter?
- No. Spectrobid is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Spectrobid come in?
- Spectrobid is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Spectrobid FDA-registered?
- Spectrobid is on record with the U.S. FDA under application number NDA050556. You can verify this on its official FDA label.
- Has Spectrobid been recalled by the FDA?
- Spectrobid has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Spectrobid safe?
- There's no single safe-or-not verdict. pharmaranks gives Spectrobid a recall-safety score of 60/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about BACAMPICILLIN HYDROCHLORIDE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 4 reports naming BACAMPICILLIN HYDROCHLORIDE — the active ingredient in Spectrobid, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- diarrhoea2 reports
- blood lactate dehydrogenase increased1 reports
- diffuse alveolar damage1 reports
- dyspnoea exertional1 reports
- hypoglycaemia1 reports
- hypokalaemia1 reports
- interstitial lung disease1 reports
- leukoencephalopathy1 reports
Read these as a signal, not a rate. A report does not mean BACAMPICILLIN HYDROCHLORIDE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
azasite
Azithromycin
bethkis
Tobramycin
cayston
Aztreonam
cefixime
Cefixime
cefotan
Cefotetan Disodium
gentamicin sulfate
Gentamicin Sulfate
Compare Spectrobid head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
spectrobid
60/100